Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conversion from BID to OAD Cyclosporine in Liver Transplant
NCT00171509Phase 4Completed
- Sponsor
- Novartis
- Start
- May 2004
- Primary completion
- Oct 2005
- Modality
- Peptides, Small Molecules
01
Overview
Phase 4, randomised, open-label trial of cyclosporine in Liver transplant rejection (3 arms), sponsored by Novartis. Primary endpoint: Proportion of patients with an improving GFR at 15 weeks. Started May 2004; status: completed.
02
Drugs
cyclosporine
03
Conditions
Liver transplant rejection
Beyond the preview
Go deeper on NCT00171509.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00171509.